These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8318804)

  • 21. [Treatment of girls with Turner's syndrome with growth hormone and estrogen--1-year experiences].
    Naeraa RW; Nielsen J; Kastrup KW
    Ugeskr Laeger; 1992 Jun; 154(25):1773-8. PubMed ID: 1632017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Growth hormone therapy in Turner's syndrome: analysis of the effect of therapy on the final height].
    Rosenfeld R
    Probl Endokrinol (Mosk); 1994; 40(2):68-71. PubMed ID: 8197099
    [No Abstract]   [Full Text] [Related]  

  • 23. What is the rationale for growth hormone therapy in Turner's syndrome?
    Cianfarani S; Vaccaro F; Boscherini B
    Lancet; 1994 Jul; 344(8915):114-5. PubMed ID: 7912351
    [No Abstract]   [Full Text] [Related]  

  • 24. Slow baseline growth and a good response to growth hormone (GH) therapy are related to elevated spontaneous GH pulse frequency in girls with Turner's syndrome.
    Kamp GA; Kuilboer MM; Wynne HJ; Rongen-Westerlaken C; Johnson ML; Veldhuis JD; Wit JM
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1604-9. PubMed ID: 8501169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone treatment in Turner's syndrome.
    Takano K; Hizuka N; Shizume K
    Acta Paediatr Scand Suppl; 1986; 325():58-63. PubMed ID: 3473892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of 94 patients with Turner's syndrome with recombinant human growth hormone (SM-9500) for two years--the results of a multicentric study in Japan. Committee for the Treatment of Turner's Syndrome.
    Takano K; Shizume K; Hibi I
    Endocrinol Jpn; 1989 Aug; 36(4):569-78. PubMed ID: 2684622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.
    Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; Hokken-Koelega AC; Waelkens JJ; Massa GG; Vulsma T; Gerver WJ; Reeser HM; Delemarre-van de Waal HE; Jansen M; Drop SL
    Arch Dis Child; 1999 Jan; 80(1):36-41. PubMed ID: 10325756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone treatment in girls with Turner's syndrome. A review of the literature.
    Wilton P
    Acta Paediatr Scand; 1987 Mar; 76(2):193-200. PubMed ID: 3296625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Growth hormone for Turner's syndrome].
    Fishman A; Hochberg Z
    Harefuah; 1991 Nov; 121(9):281-6. PubMed ID: 1800273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study.
    Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; van Leeuwen WJ; Asarfi A; van Rijn RR; Drop SL;
    Pediatr Res; 2001 Sep; 50(3):417-22. PubMed ID: 11518831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone treatment in Turner's syndrome: short and long-term effects on metabolic parameters.
    Haeusler G; Frisch H
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):247-53. PubMed ID: 1563078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone therapy for patients with Turner's syndrome.
    Singer-Granick C; Lee PA; Foley TP; Becker DJ
    Horm Res; 1986; 24(4):246-50. PubMed ID: 3781482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of 80 patients with Turner's syndrome with recombinant human growth hormone (YM-17798) for one year: the results of a multicentric study in Japan. Committee for the Treatment of Turner's Syndrome.
    Takano K; Shizume K; Hibi I
    Endocrinol Jpn; 1989 Apr; 36(2):253-60. PubMed ID: 2673750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone therapy in Turner's syndrome.
    O'Shea D; Powell D
    Ir Med J; 1992 Jun; 85(2):68-9. PubMed ID: 1628947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Change in speaking fundamental frequency in hormone-treated patients with Turner's syndrome--a longitudinal study of four cases.
    Andersson-Wallgren G; Albertsson-Wikland K
    Acta Paediatr; 1994 Apr; 83(4):452-5. PubMed ID: 8025411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Mouton JW; Blum WF; Mercado M; Baumann G; Drop SL
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):77-84. PubMed ID: 7688672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome.
    Lu PW; Cowell CT; Jimenez M; Simpson JM; Silink M
    Arch Dis Child; 1991 Oct; 66(10):1184-90. PubMed ID: 1953000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in craniofacial development induced by growth hormone therapy in children treated with bone marrow transplantation.
    Dahllöf G; Forsberg CM; Borgström B
    Acta Paediatr; 1994 Nov; 83(11):1165-9. PubMed ID: 7841732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re: A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 2000 Dec; 53(6):760-1. PubMed ID: 11155102
    [No Abstract]   [Full Text] [Related]  

  • 40. Growth hormone in short, slowly growing children and those with Turner's syndrome.
    Buchanan CR; Law CM; Milner RD
    Arch Dis Child; 1987 Sep; 62(9):912-6. PubMed ID: 3314726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.